Lori A Carr Doctors at Massachusetts General Hospital are hoping electrode implants can deliver deep brain stimulation (DBS) that could eventually help treat an array of psychiatric illnesses ranging from post-traumatic stress disorder (PTSD) to schizophrenia.
Researchers published in the winter of 2014 on the creation of a biodegradable adhesive patch to repair holes in the heart. Now, they have developed a UV-light-based catheter that can deliver the patch, thereby obviating the need for open-heart surgery, sutures or stoppage of the heart. This latest work, as well as the initial patch development, was published in the journal Science Translational Medicine.
The U.S. Food and Drug Administration (FDA) is warning the public about eye drop bottles that have loose plastic safety seals or tamper evident rings below the bottle cap that may fall onto the eye when the product is used.
A patent filing reveals that Apple is developing a ring computing device. Worn on the finger, the gizmo is expected to house technology that includes biometric sensors for monitoring cardiac rhythm and perspiration.
As scientists explore the genetic underpinnings of disease to help develop new diagnostics and treatments, an NIH-backed team of researchers is creating the world’s largest database of human genomic variation aimed at clinical use.
A group of bioengineers have developed a noninvasive, portable device that resembles a finger-worn, pulse oximeter to count white blood cells. They have three workable prototypes that are being tested with chemotherapy patients to track their immune system in real-time. The researchers aim to have an initial beta product that it can support via crowdfunding in 2017, with a product on the market potentially in 2019.
Oraya Therapeutics seeks to reduce the number of eye injections required to treat wet age-related macular degeneration, the leading cause of blindness in the developed world. It’s CE-marked X-ray device safely delivers radiation to the back of the eye, improving the efficacy of anti-VEGF injectable eye drugs like Genentech’s Lucentis.
Despite an intense flurry of pushback, the U.S. Senate voted Wednesday to confirm cardiologist Robert Califf as the next Commissioner of the FDA. The Senate had passed a procedural vote two days prior; however, several Senators had held up the final vote the following day in an effort to push the Agency to be more engaged in its review of opioid analgesics.
As medical experts question the efficacy of mammograms in breast cancer screening, a new study shows that computer-aided detection technology (CAD) used during the process does not help spot cancer in patients.
In an effort aimed at encouraging earlier diagnosis and even potentially prevention for Type 1 diabetes, the JDRF and the American Diabetes Association (ADA) have published a new evaluation of the presymptomatic staging of Type 1 diabetes. Currently, Type 1 diabetes is typically not diagnosed until the patient in symptomatic–frequently in the emergency room with acute symptoms.